Phase I study combining pembrolizumab and aromatase inhibitor in patients with metastatic hormone receptor–positive breast cancer.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Xuan Ge, Susan Elaine Yost, Jin Sun Lee, Paul Henry Frankel, Christopher Ruel, Yujie Cui, Mireya Murga, Aileen Tang, Norma Martinez, Samuel Chung, Christina Haeyoung Yeon, Daphne B. Stewart, Daneng Li, Swapnil Padmakar Rajurkar, George Somlo, Joanne E. Mortimer, James Ross Waisman, Yuan Yuan
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281716149